According to Haemonetics's latest financial reports and stock price the company's current number of shares outstanding is 50,447,000. At the end of 2023 the company had 50,447,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 50.44 M | -0.12% |
2022 | 50.5 M | -1.14% |
2021 | 51.09 M | 0.6% |
2020 | 50.78 M | 0.31% |
2019 | 50.63 M | -1.5% |
2018 | 51.4 M | -3.18% |
2017 | 53.09 M | 2.67% |
2016 | 51.7 M | 1.91% |
2015 | 50.74 M | -1.34% |
2014 | 51.43 M | -0.58% |
2013 | 51.73 M | 0.04% |
2012 | 51.7 M | 106.19% |
2011 | 25.07 M | 0.42% |
2010 | 24.97 M | -1.25% |
2009 | 25.28 M | -0.34% |
2008 | 25.37 M | -0.49% |
2007 | 25.5 M | -3.87% |
2006 | 26.52 M | -0.06% |
2005 | 26.54 M | 3.57% |
2004 | 25.62 M | 4.53% |
2003 | 24.51 M | 0.92% |
2002 | 24.29 M | -8.13% |
2001 | 26.44 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,598,734,075 | 5,051.41% | ๐บ๐ธ USA |
![]() Medtronic MDT | 1,330,400,000 | 2,537.22% | ๐ฎ๐ช Ireland |
![]() Thermo Fisher Scientific TMO | 386,000,000 | 665.16% | ๐บ๐ธ USA |
![]() Baxter BAX | 505,000,000 | 901.05% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | 284,292,000 | 463.55% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | 379,000,000 | 651.28% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | 126,285,000 | 150.33% | ๐บ๐ธ USA |
![]() Cerus CERS | 178,273,000 | 253.39% | ๐บ๐ธ USA |